Now, if we took a GLP-1, we would get that signal loud and clear and also reduce our appetite
Specific medication choice is discussed during consultation
The relationship between GLP-1 therapies and atrial fibrillation is an emerging topic in diabetes care, raising an important question: could medications designed to protect the heart also influence its rhythm
A class action is different because one or more representatives pursue a single case on behalf of a defined group, and outcomes can bind class members who do not opt out
K., MacDougall, K., Preston, T., Tedford, C., Finlayson, G
Clinical trials have shown impressive results: people taking tirzepatide , alongside a reduced-calorie diet and increased physical activity, lost on average 15% to 22% of their body weight over about 72 weeks